Delivery Order SPE2DB22D3501-SPE2DB25FWB68
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,467.19 to AmerisourceBergen Drug Corp for Paclitaxel Protein-Bound 100mg on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract has no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $8,649.54 firm fixed price delivery order to AmerisourceBergen Drug Corp for Paclitaxel Protein-Bound 100mg on September 3, 2025, with an ultimate completion date of September 4, 2025. This non-set-aside delivery order is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under the vendor's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Paclitaxel Protein-Bound 100mg, a chemotherapy medication. The delivery order, valued at $8,312.02 with a firm fixed price structure, carries an ultimate completion date of April 24, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken, Pennsylvania, leveraging its...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Paclitaxel Protein-Bound 100mg pharmaceutical product. This firm fixed-price delivery order, valued at $16,027.18, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery location is AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,650.26 on August 6, 2025, for Paclitaxel Protein-Bound 100mg pharmaceutical product. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 7, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $10,443.06 to AmerisourceBergen Drug Corp for Paclitaxel Protein-Bound 100mg on September 25, 2025, with completion scheduled for September 26, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The contract calls for the supply of this specialized oncology medication to support federal...
- The Defense Logistics Agency awarded a $11,158.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Paclitaxel Protein-Bound 100mg on August 6, 2025, with completion scheduled for August 7, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical support for military healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $11,596.30 to AmerisourceBergen Drug Corp for the supply of Paclitaxel Protein-Bound 100mg on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed price, non-set-aside contract is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- This delivery order, awarded on June 17, 2025, represents a $7,553.38 firm fixed price purchase of Paclitaxel Protein-Bound 100mg pharmaceutical product from AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The award was made by the Defense Logistics Agency (DLA), a Department of Defense component responsible for supply chain management across military operations and healthcare systems. The contract is unclassified as a set-aside and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Paclitaxel 300 mg/50 ml vials with a firm fixed price ceiling value of $1,126.20. This delivery order represents a non-set-aside, competitively awarded procurement supporting the federal government's pharmaceutical supply requirements. The award is fulfillment under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWB68Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,085.18 to AmerisourceBergen Drug Corp for Paclitaxel Protein-Bound 100mg on June 17, 2025, with an ultimate completion date of June 18, 2025. The contract employs firm fixed price terms with no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. This award is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the contractor to supply medications, vaccines, medical devices, and specialized healthcare commodities to military healthcare systems and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The Paclitaxel order fulfills critical oncology medication needs within the Defense Health Agency's medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 6/17/25 |